Bordetella bronchiseptica Glycosyltransferase Core Mutants Trigger Changes in Lipid A Structure
Bordetella bronchiseptica, known to infect animals and rarely humans, expresses a lipopolysaccharide that plays an essential role in host interactions, being critical for early clearance of the bacteria. On a B. bronchiseptica 9.73 isolate, mutants defective in the expression of genes involved in the biosynthesis of the core region were previously constructed. Herein, a comparative detailed structural analysis of the expressed lipids A by MALDI-TOF mass spectrometry was performed. The Bb3394 LPS defective in a 2-amino-2-deoxy-d-galacturonic acid lateral residue of the core presented a penta-acylated diglucosamine backbone modified with two glucosamine phosphates, similar to the wild-type lipid A. In contrast, BbLP39, resulting in the interruption of the LPS core oligosaccharide synthesis, presented lipid A species consisting in a diglucosamine backbone N-substituted with C14:0(3-O-C12:0) in C-2 and C14:0(3-O-C14:0) in C-2′, O-acylated with C14:0(3-O-C10:0(3-OH) in C-3′ and with a pyrophosphate in C-1. Regarding Bb3398 also presenting a rough LPS, the lipid A is formed by a hexa-acylated diglucosamine backbone carrying one pyrophosphate group in C-1 and one phosphate in C-4′, both substituted with ethanolamine groups. As far as we know, this is the first description of a phosphoethanolamine modification in B. bronchiseptica lipid A. Our results demonstrate that although gene deletions were not directed to the lipid A moiety, each mutant presented different modifications. MALDI-TOF mass spectrometry was an excellent tool to highlight the structural diversity of the lipid A structures biosynthesized during its transit through the periplasm to the final localization in the outer surface of the outer membrane.
KeywordsB. bronchiseptica Lipopolysaccharide UV-MALDI-TOF MS Lipid A modifications
This work was supported by CONICET, Grant PIP-11220110100660, and by ANPCyT, (Grant PICT 2013-0736 and 2013-0092) and UBA Grant 20020130100476BA. The Ultraflex II (Bruker) TOF/TOF mass spectrometer was supported by ANPCyT Grant PME 125 (CEQUIBIEM). A.C. and F.S. are members of the Scientific Career of CONICET.
- 3.Trent, M.S., Stead, C.M., Tran, A.X., Hankins, J.V.: Diversity of endotoxin and its impact on pathogenesis. J. Endotoxin Res. 12, 205–223 (2006)Google Scholar
- 17.Preston, A., Maxim, E., Toland, E., Pishko, E.J., Harvill, E.T., Caroff, M., Maskell, D.J.: Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol. Microbiol. 48, 725–736 (2003)CrossRefGoogle Scholar
- 18.Basheer, S.M., Guiso, N., Tirsoaga, A., Caroff, M., Novikov, A.: Structural modifications occurring in lipid A of Bordetella bronchiseptica clinical isolates as demonstrated by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 25, 1075–1081 (2011)CrossRefGoogle Scholar
- 19.Rolin, O., Muse, S.J., Safi, C., Elahi, S., Gerdts, V., Hittle, L.E., Ernst, R.K., Harvill, E.T., Preston, A.: Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission. Infect. Immun. 82, 491–499 (2014)CrossRefGoogle Scholar
- 23.Darveau, R.P., Hancock, R.E.: Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J. Bacteriol. 155(2), 831–838 (1983)Google Scholar
- 27.Marr, N., Hajjar, A.M., Shah, N.R., Novikov, A., Yam, C.S., Caroff, M., Fernandez, R.C.: Substitution of the Bordetella pertussis lipid a phosphate groups with glucosamine is required for robust NF-κB activation and release of proinflammatory cytokines in cells expressing human but not murine toll-like receptor 4-MD-2-CD14. Infect Immun. 78, 2060–2069 (2010)CrossRefGoogle Scholar